Correlation | SMD | Placebo, N (%) | Active treatment, N (%) |
---|---|---|---|
Strong Negative | 47 (19.9%) | 29 (12.9%) | 34 (15.1%) |
Moderate Negative | 38 (16.1%) | 16 (7.1%) | 31 (13.8%) |
Weak Negative | 53 (22.5%) | 47 (20.9%) | 51 (22.7%) |
Weak Positive | 45 (19.1%) | 60 (26.7%) | 58 (25.8%) |
Moderate Positive | 32 (13.6%) | 35 (15.6%) | 18 (8%) |
Strong Positive | 21 (8.9%) | 38 (16.9%) | 33 (14.7%) |
Total | 236. (100%) | 226 (100%) | 226 (100%) |